CORPORATES Marksans Pharma gets final USFDA approval for Loperamide Hydrochloride Tablets Nov 19, 2025
CORPORATES Marksans Pharma secures UK MHRA approval for 250 mg and 500 mg Mefenamic Acid Nov 17, 2025
Marksans Pharma’s subsidiary Relonchem gets UK approval for Ibuprofen and Paracetamol tablets Feb 25, 2025
Marksans Pharma shares jump 2% following USFDA approval for Loratadine Tablets USP 10 mg Nov 22, 2024
Marksans Pharma Q2 FY25: Revenue up 20.84% YoY to Rs 641.92 crore, Net Profit up 16.56% YoY Nov 12, 2024